Enzyme with &bgr;-1,3-glucanase activity
    22.
    发明授权
    Enzyme with &bgr;-1,3-glucanase activity 失效
    具有β-1,3-葡聚糖酶活性的酶

    公开(公告)号:US06284509B1

    公开(公告)日:2001-09-04

    申请号:US09159106

    申请日:1998-09-23

    IPC分类号: C12N924

    摘要: The present invention relates to a DNA construct exhibiting &bgr;-1,3-glucanase activity, which DNA sequence comprises: a) the DNA sequence shown in SEQ ID No. 1 or SEQ ID No. 12, or b) an analogue of the DNA sequence defined in a), which i) is homologous with the DNA sequence defined in a), or ii) hybridizes with the same oligonucleotide probe as the DNA sequence defined in a), or iii) encodes a polypeptide which is homologous with the polypeptide encoded by a DNA sequence comprising the DNA sequence defined in a), or iv) encodes a polypeptide which is immunologically reactive with an antibody raised against the purified &bgr;-1,3-glucanase derived from Oerksovia xanthineolytica LLG109 encoded by the DNA sequence defined in a). The DNA construct may further encode a mannose binding domain. The invention also relates to a DNA construct encoding a mannose binding domain. Further the invention relates to an expression vector comprising said DNA constructs, a cell harbouring said DNA constructs or expression vectors, a method of producing the novel enzyme, a novel enzyme preparation containing said novel enzyme, the use of the enzyme for degrading or modification of &bgr;-glucan containing material.

    摘要翻译: 本发明涉及显示β-1,3-葡聚糖酶活性的DNA构建体,该DNA序列包含:a)SEQ ID No.1或SEQ ID No.12所示的DNA序列,或b)DNA的类似物 a)中定义的序列,其i)与a)中定义的DNA序列同源,或ii)与与a)中定义的DNA序列相同的寡核苷酸探针杂交,或iii)编码与多肽同源的多肽 由包含a)中定义的DNA序列的DNA序列编码,或iv)编码与针对衍生自由Okssovia xanthineolytica LLG109纯化的β-1,3-葡聚糖酶产生的抗体免疫反应性的多肽,其由 一个)。 DNA构建体可以进一步编码甘露糖结合结构域。 本发明还涉及编码甘露糖结合结构域的DNA构建体。 此外,本发明涉及包含所述DNA构建体,含有所述DNA构建体或表达载体的细胞的表达载体,产生所述新酶的方法,含有所述新酶的新型酶制剂,所述酶用于降解或修饰 含β-葡聚糖的材料。

    Protease variants
    25.
    发明授权
    Protease variants 失效
    蛋白酶变体

    公开(公告)号:US6087315A

    公开(公告)日:2000-07-11

    申请号:US852790

    申请日:1997-05-07

    摘要: The present invention relates to protease variants, stabilized towards the inactivation caused by peroxidase systems, in which protease variants a naturally occurring tyrosine residue has been deleted or substituted with a different amino acid residue at one or more positions. The invention also relates to a method of stabilizing a protease towards the inactivation caused by peroxidase systems, and detergent compositions comprising a protease variant of the invention.

    摘要翻译: 本发明涉及针对由过氧化物酶体系引起的失活而稳定的蛋白酶变体,其中蛋白酶变体天然存在的酪氨酸残基已被缺失或被一个或多个位置上的不同氨基酸残基所取代。 本发明还涉及一种将过氧化物酶系统引起的灭活蛋白酶稳定化的方法,以及包含本发明的蛋白酶变体的洗涤剂组合物。

    Alkaline lipolytic enzyme
    26.
    发明授权
    Alkaline lipolytic enzyme 失效
    碱性脂解酶

    公开(公告)号:US5919746A

    公开(公告)日:1999-07-06

    申请号:US919724

    申请日:1997-08-28

    CPC分类号: C11D3/38627 C12N9/20

    摘要: The present invention relates to an alkaline lipolytic enzyme derivable from a strain of Botryosphaeria or Guignardia, to a lipolytic enzyme-producing microbial strain, to methods for the production of lipolytic enzyme and to a detergent composition comprising the lipolytic enzyme.

    摘要翻译: 本发明涉及可从Botryosphaeria或Guignardia菌株衍生的碱性脂肪分解酶,产生脂肪分解酶的微生物菌株,生产脂肪分解酶的方法和包含该脂肪分解酶的洗涤剂组合物。

    Recombinant lipase and alpha-amylase variants
    28.
    发明授权
    Recombinant lipase and alpha-amylase variants 失效
    重组脂肪酶和α-淀粉酶变体

    公开(公告)号:US5731280A

    公开(公告)日:1998-03-24

    申请号:US448540

    申请日:1995-06-15

    摘要: The present invention relates to lipase and .alpha.-amylase variants, stabilized towards the inactiviation caused by peroxidase systems, in which variants a naturally occurring tryosine residue has been deleted, substituted with a different amino acid residue at one or more positions. The invention also relates to a method of stabilizing a lipase or an .alpha.-amylase towards the inactivation caused by the preoxidase systems, and detergent compositions comprising a lipase and/or .alpha.-amylase variant of the invention.

    摘要翻译: PCT No.PCT / DK93 / 00441 Sec。 371日期:1995年6月15日 102(e)日期1995年6月15日PCT 1993年12月22日PCT公布。 第WO94 / 14951号公报 日期1994年7月7日本发明涉及针对由过氧化物酶系统引起的失活而稳定的脂肪酶和α-淀粉酶变体,其中天然存在的软糖残基已被缺失,在一个或多个位置被不同的氨基酸残基取代 。 本发明还涉及一种使脂肪酶或α-淀粉酶稳定化为由前体氧化酶系统引起的失活的方法,以及包含本发明的脂肪酶和/或α-淀粉酶变体的洗涤剂组合物。

    METHOD FOR PREPARING MODIFIED POLYPEPTIDES
    29.
    发明申请
    METHOD FOR PREPARING MODIFIED POLYPEPTIDES 审中-公开
    制备改性多糖的方法

    公开(公告)号:US20120107852A1

    公开(公告)日:2012-05-03

    申请号:US13272681

    申请日:2011-10-13

    IPC分类号: C12Q1/48

    摘要: Methods for producing polypeptide with altered immunogenicity or improved stability properties are disclosed. The methods involve a) expressing a diversified population of nucleotide sequences encoding a polypeptide of interest, b) screening the polypeptides expressed in step a) for function, immunogenicity and/or stability, c) selecting functional polypeptides having altered immunogenicity and/or increased stability, e.g. functional in vivo half-life as compared to the polypeptide of interest, and d) optionally subjecting the nucleotide sequence encoding the polypeptide selected in step c) to one or more repeated cycles of steps a)-c). In a further step the expressed polypeptides of step a) or c) can be conjugated to at least one non-polypeptide moiety.

    摘要翻译: 公开了产生具有改变的免疫原性或改善的稳定性的多肽的方法。 所述方法包括:a)表达编码感兴趣多肽的核苷酸序列的多样化群体,b)筛选功能,免疫原性和/或稳定性在步骤a)中表达的多肽,c)选择具有改变的免疫原性和/或增加稳定性的功能性多肽 ,例如 与目的多肽相比具有功能的体内半衰期,和d)任选地将编码步骤c)中选择的多肽的核苷酸序列经历步骤a)-c)的一个或多个重复循环。 在另一步骤中,步骤a)或c)的表达多肽可以与至少一个非多肽部分缀合。

    RANK LIGAND-BINDING POLYPEPTIDES
    30.
    发明申请
    RANK LIGAND-BINDING POLYPEPTIDES 审中-公开
    RANK配体结合多肽

    公开(公告)号:US20090017499A1

    公开(公告)日:2009-01-15

    申请号:US11942684

    申请日:2007-11-19

    IPC分类号: C12P21/02 C07K14/47 C12N15/62

    CPC分类号: C07K14/70578 C07K2319/00

    摘要: The present invention relates to a polypeptide having an amino acid sequence that differs from and is at least 70% identical to the amino acid sequence of hRANK, and which has a binding affinity to RANKL that is at least as high as the binding affinity of hRANK to RANKL, as determined by the functional competition assay described herein.

    摘要翻译: 本发明涉及具有与hRANK的氨基酸序列不同且至少70%相同的氨基酸序列的多肽,并且其与RANKL的结合亲和力至少与hRANK的结合亲和力一样高 通过本文所述的功能竞争测定法确定的RANKL。